PM: decision on the application for modification of an agreed PIP
Decision date
Compliance procedure number
EMEA-C-001219-PIP01-11-M06
Compliance opinion date
Compliance outcome
Positive
Decision
P/0038/2023 : EMA decision of 31 January 2023 on the acceptance of a modification of an agreed paediatric investigation plan for dolutegravir / abacavir / lamivudine (Triumeq), (EMEA-001219-PIP01-11-M06)